Table 2.
Scores of SF-36 before starting treatment (BASAL), at the end of therapy (EOT), and 1 year after EOT (n=15).
| |
BASAL | EOT | 1 YEAR | p value |
|---|---|---|---|---|
| Health Change a | 50 (25-100) | 50 (25-100) | 75 (25-100) † | 0.01129 |
|
| ||||
| General Health | 42 (28.59) | 50.3 (26.69) | 47.3 (23.82) | 0.1018 |
|
| ||||
| Physical Functioning a | 70 (20-100) | 75 (0-100) | 90 (0-100) | 0.3359 |
|
| ||||
| Role limitation – Physical a | 50 (0-100) | 100 (25-100) | 100 (0-100) | 0.006152 |
|
| ||||
| Role limitation – Emotional a | 33.3 (0-100) | 100 (0-100) † | 100 (0-100) † | 0.0145 |
|
| ||||
| Social role functioning a | 62.50 (25-100) | 75 (25-100) | 87.50 (25-100) † | 0.08548 |
|
| ||||
| Bodily Pain a | 77.5 (22.5-100) | 90 (22.5-100) | 90 (0-100) | 0.09072 |
|
| ||||
| Emotional well-being b | 57.6 (18.57) | 70.13 (12.99) § | 73.87 (12.82) § | 8e -04 |
|
| ||||
| Vitality b | 56.3 (22.16) | 68 (10.82) | 66.67 (20.41) | 0.0807 |
Data are expressed as a median values (range) or b mean (standard deviation). † p<0.05 vs BASAL (Friedman's test followed by Bonferroni's correction); § p<0.05 vs BASAL (ANOVA followed by Tukey post hoc test).